BRAIN Biotech AG (BNN) - Cash Flow Conversion Efficiency

Latest as of September 2025: -2.326x

Based on the latest financial reports, BRAIN Biotech AG (BNN) has a cash flow conversion efficiency ratio of -2.326x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-4.28 Million ≈ $-5.01 Million USD) by net assets (€1.84 Million ≈ $2.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BNN defensive interval ratio to measure how many days the company can operate on defensive assets alone.

BRAIN Biotech AG - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how BRAIN Biotech AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BRAIN Biotech AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BRAIN Biotech AG ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Futuretech II Acquisition Corp NASDAQ:FTII	-3.681x
Shenzhen SEG Co Ltd SHE:200058	0.108x
Linz Textil Holding AG VI:LTH	0.058x
Allegiant Gold Ltd V:AUAU	-0.013x
Hofseth Biocare ASA OL:HBC	0.167x
Waskita Beton Precast Tbk PT JK:WSBP	0.008x
ICE FISH FARM AS NK-10 F:4YYA	0.013x
Helixmith Co. Ltd KQ:084990	-0.013x

Annual Cash Flow Conversion Efficiency for BRAIN Biotech AG (2012–2025)

The table below shows the annual cash flow conversion efficiency of BRAIN Biotech AG from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see BNN market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-09-30	€1.84 Million ≈ $2.15 Million	€-9.23 Million ≈ $-10.79 Million	-5.015x	-1843.65%
2024-09-30	€13.89 Million ≈ $16.23 Million	€-3.58 Million ≈ $-4.19 Million	-0.258x	-40.78%
2023-09-30	€23.01 Million ≈ $26.91 Million	€-4.22 Million ≈ $-4.93 Million	-0.183x	-322.69%
2022-09-30	€34.25 Million ≈ $40.04 Million	€-1.49 Million ≈ $-1.74 Million	-0.043x	+53.57%
2021-09-30	€41.83 Million ≈ $48.90 Million	€-3.91 Million ≈ $-4.57 Million	-0.093x	+48.79%
2020-09-30	€26.14 Million ≈ $30.56 Million	€-4.77 Million ≈ $-5.57 Million	-0.182x	+7.80%
2019-09-30	€17.09 Million ≈ $19.98 Million	€-3.38 Million ≈ $-3.95 Million	-0.198x	-11.84%
2018-09-30	€30.64 Million ≈ $35.82 Million	€-5.42 Million ≈ $-6.33 Million	-0.177x	-45.48%
2017-09-30	€47.36 Million ≈ $55.37 Million	€-5.76 Million ≈ $-6.73 Million	-0.122x	+62.31%
2016-09-30	€26.93 Million ≈ $31.48 Million	€-8.68 Million ≈ $-10.15 Million	-0.322x	+54.88%
2015-09-30	€5.76 Million ≈ $6.73 Million	€-4.11 Million ≈ $-4.81 Million	-0.715x	-153.56%
2014-09-30	€13.85 Million ≈ $16.19 Million	€-3.90 Million ≈ $-4.56 Million	-0.282x	-2.26%
2013-09-30	€17.59 Million ≈ $20.57 Million	€-4.85 Million ≈ $-5.67 Million	-0.276x	+43.22%
2012-09-30	€12.12 Million ≈ $14.17 Million	€-5.89 Million ≈ $-6.88 Million	-0.485x	--

About BRAIN Biotech AG

XETRA:BNN Germany Specialty Chemicals

Market Cap

$73.05 Million

€62.48 Million EUR

Market Cap Rank

#21856 Global

#1947 in Germany

Share Price

€2.86

Change (1 day)

+0.70%

52-Week Range

€1.85 - €3.66

All Time High

€27.50